Purple Biotec-L AI Stock Analysis
Want to see IL:PPBT.L full AI Analyst Report?
Purple Biotec-L (PPBT.L) AI Stock Analysis
Purple Biotec-L
(TASE:PPBT.L)
No summary available
Purple Biotec-L (PPBT.L) vs. iShares MSCI Israel ETF (EIS)
- Market Cap
- ILS 32.37M
- Dividend Yield
- ―
- Average Volume (3M)
- 110.22K
- Price to Earnings (P/E)
- -0.0
- Beta (1Y)
- 0.24
- Revenue Growth
- ―
- EPS Growth
- -125.74%
- Country
- Israel
- Employees
- 10
- Sector
- General
- Sector Strength
- 55
- Industry
- Biotechnology
Purple Biotec-L Business Overview & Revenue Model
Company Description
Purple Biotech Ltd., a clinical-stage company, is focused on creating therapies for cancer patients in the United States, specifically addressing challenges like tumor immune evasion and drug resistance. Its diverse oncology pipeline includes CM24, a...
How the Company Makes Money
Purple Biotech’s revenue model is primarily partnership- and licensing-based rather than product-sales-based, as it is a clinical-stage company and does not have a broad portfolio of commercialized products (commercial product revenue: null). The com...
Purple Biotec-L Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IL:PPBT.L, the sentiment is Negative. The current price of 1.00 is above the 20-day moving average (MA) of 1.00, above the 50-day MA of 1.00, and below the 200-day MA of 1.01, indicating a neutral trend. The MACD of -0.00 indicates Negative momentum. The RSI at 40.97 is Neutral, neither overbought nor oversold. The STOCH value of -0.00 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IL:PPBT.L.
Purple Biotec-L Peers Comparison
Overall Rating
IL:BLRX41Neutral
IL:CANF39Underperform
Financial Indicators
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| IL:PPBT.L | Purple Biotec-L | 1.00 | -0.20 | -16.67% | |
| IL:XTLB | XTL Biopharmaceuticals Ltd. | 1.30 | -2.00 | -60.61% | |
| IL:CBI | Clal Biotechnology Industries Ltd | 21.90 | -11.50 | -34.43% | |
| IL:BLRX | BioLineRX Ltd. | 1.00 | -0.90 | -47.37% | |
| IL:CANF | Can-Fite BioPharma Ltd. | 261.40 | 260.40 | 26040.00% | |
| IL:MTLF | Matricelf Ltd. | 240.80 | -189.50 | -44.04% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.